Other authors have demonstrated that high PD-L1 expression in head and neck cancer patients is not related to OS, but correlated with several clinicopathological features, such as sex, histological differentiation, distant metastasis, and HPV status, thus appearing to be indicative of better patient prognosis [11,12]. This evidence concerns the gene CD274 and head and neck cancer.